SCHEMBL23919268

SCHEMBL23919268

CCc1ccc2c(oc3ccccc32)c1N(c1cccc(C)c1)c1ccc2ccc3c(N(c4cccc(C)c4)c4c(CC)ccc5c4oc4ccccc45)ccc4ccc1c2c43

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.37
HPGD P15428 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TP53 P04637 2/20 0.33
ALOX5 P09917 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
USP2 O75604 2/20 0.32
ALOX15 P16050 2/20 0.32
MAPT P10636 3/20 0.32
PPARG P37231 2/20 0.32
RXFP1 Q9HBX9 2/20 0.32
NCOR2 Q9Y618 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
LMNA P02545 2/20 0.31
NR2E3 Q9Y5X4 1/20 0.31
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 2/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23919272 0.92 ALOX5 (0.32) ALDH1A1HPGDSMN1; SMN2ALOX5MEN1
SCHEMBL23919275 0.91 ALOX5 (0.35) ALDH1A1HPGDSMN1; SMN2ALOX5TDP1
SCHEMBL23919269 0.89 CYP1A1 (0.34) ALDH1A1HPGDALOX5KDM4EL3MBTL1
SCHEMBL23919450 0.88 ALDH1A1 (0.33) ALDH1A1HPGDSMN1; SMN2TP53ALOX5
SCHEMBL23919292 0.85 TP53 (0.32) ALDH1A1HPGDSMN1; SMN2TP53ALOX5
SCHEMBL19165607 0.84 ALDH1A1 (0.35) ALDH1A1HPGDSMN1; SMN2TP53ALOX5
SCHEMBL12206523 0.84 ALDH1A1 (0.34) ALDH1A1HPGDSMN1; SMN2TP53ALOX5
SCHEMBL23919260 0.84 ALDH1A1 (0.31) ALDH1A1HPGDSMN1; SMN2ALOX5MEN1
SCHEMBL23919280 0.83 TP53 (0.34) ALDH1A1HPGDSMN1; SMN2TP53ALOX5
SCHEMBL23919281 0.83 MEN1 (0.32) ALDH1A1ALOX5MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO.,LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320251-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE OLA1, TAS2R19, TMEM109 ALDH1A1 541/4885HPGD 4701/4885SMN1; SMN2 2558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.